JP2014503174A5 - - Google Patents

Download PDF

Info

Publication number
JP2014503174A5
JP2014503174A5 JP2012537426A JP2012537426A JP2014503174A5 JP 2014503174 A5 JP2014503174 A5 JP 2014503174A5 JP 2012537426 A JP2012537426 A JP 2012537426A JP 2012537426 A JP2012537426 A JP 2012537426A JP 2014503174 A5 JP2014503174 A5 JP 2014503174A5
Authority
JP
Japan
Prior art keywords
chimeric virus
particle according
seq
subunit
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012537426A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014503174A (ja
JP5795319B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/ES2010/070717 external-priority patent/WO2011054996A2/es
Publication of JP2014503174A publication Critical patent/JP2014503174A/ja
Publication of JP2014503174A5 publication Critical patent/JP2014503174A5/ja
Application granted granted Critical
Publication of JP5795319B2 publication Critical patent/JP5795319B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012537426A 2009-11-06 2010-11-05 ヒトパピローマウイルス抗原を含むビルナウイルスのウイルスカプシドに基づく腫瘍形成を処置するためのワクチン Expired - Fee Related JP5795319B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ES200930967 2009-11-06
ESP200930967 2009-11-06
PCT/ES2010/070717 WO2011054996A2 (es) 2009-11-06 2010-11-05 Vacunas para el tratamiento de neoplasias a partir de capsides virales de birnavirus conteniendo antigenos del virus del papiloma humano

Publications (3)

Publication Number Publication Date
JP2014503174A JP2014503174A (ja) 2014-02-13
JP2014503174A5 true JP2014503174A5 (cg-RX-API-DMAC7.html) 2014-04-03
JP5795319B2 JP5795319B2 (ja) 2015-10-14

Family

ID=43970455

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012537426A Expired - Fee Related JP5795319B2 (ja) 2009-11-06 2010-11-05 ヒトパピローマウイルス抗原を含むビルナウイルスのウイルスカプシドに基づく腫瘍形成を処置するためのワクチン

Country Status (7)

Country Link
US (1) US8951534B2 (cg-RX-API-DMAC7.html)
EP (1) EP2497494B1 (cg-RX-API-DMAC7.html)
JP (1) JP5795319B2 (cg-RX-API-DMAC7.html)
AU (1) AU2010316998B2 (cg-RX-API-DMAC7.html)
CA (1) CA2779645A1 (cg-RX-API-DMAC7.html)
ES (1) ES2667052T3 (cg-RX-API-DMAC7.html)
WO (1) WO2011054996A2 (cg-RX-API-DMAC7.html)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2284559T3 (es) * 2001-03-23 2007-11-16 Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts Genes y proteinas e6 y e7 modificados del vph utiles como vacuna.
ES2242542B1 (es) 2004-04-30 2006-12-16 Consejo Superior De Investigaciones Cientificas Procedimiento para la produccion en levaduras de capsidas virales vacias compuestas por proteinas derivadas de pvp2 del virus causante de la enfermedad de la bursitis infecciosa (ibdv).
ES2310062B1 (es) * 2005-07-15 2009-11-13 Bionostra, S.L. Particulas pseudovirales vacias quimericas derivadas del virus causante de la enfermedad de la bursitis infecciosa (ibdv), procedimiento de obtencion y aplicaciones.
EP2093281A1 (en) * 2008-02-19 2009-08-26 Kapsid Link, S.L. Protein nanocarriers, process for obtaining them and applications
DK2288618T3 (en) 2008-05-09 2018-01-08 Chimera Pharma S L U CHEMICAL FUSION PROTEINS AND VIRUS LIKE PARTICLES FROM BIRNAVIRUS VP2

Similar Documents

Publication Publication Date Title
JP6957580B2 (ja) 新規多価ナノ粒子に基づくワクチン
Tornesello et al. Virus-like particles as preventive and therapeutic cancer vaccines
JP2016533332A5 (cg-RX-API-DMAC7.html)
RU2642287C2 (ru) Химерная частица hpv
JP2016526374A5 (cg-RX-API-DMAC7.html)
JP2014530010A5 (cg-RX-API-DMAC7.html)
JP2012532601A5 (cg-RX-API-DMAC7.html)
JP2008530245A5 (cg-RX-API-DMAC7.html)
JP2013523686A5 (cg-RX-API-DMAC7.html)
JP2011528896A5 (cg-RX-API-DMAC7.html)
JP2017523796A (ja) 修飾エンベロープタンパク質e3を含むウイルス様粒子
CN103180343B (zh) 用于预防或治疗宫颈癌的、包含人乳头瘤病毒变形体及免疫增强剂的组合物
US12403190B2 (en) Coronavirus vaccine and methods of use thereof
JP2009268467A5 (cg-RX-API-DMAC7.html)
JP2008535800A5 (cg-RX-API-DMAC7.html)
JP2011521662A5 (cg-RX-API-DMAC7.html)
RU2015155821A (ru) Вакцины против малярии
JP2015506705A5 (cg-RX-API-DMAC7.html)
Shoja et al. Rotavirus VP6: involvement in immunogenicity, adjuvant activity, and use as a vector for heterologous peptides, drug delivery, and production of nano-biomaterials
JP2010538619A5 (cg-RX-API-DMAC7.html)
JP2014529399A5 (cg-RX-API-DMAC7.html)
JP2009112314A5 (cg-RX-API-DMAC7.html)
JP2010506926A5 (cg-RX-API-DMAC7.html)
CN101952320A (zh) 具有免疫原性的物质
WO2008154868A1 (en) Capsid proteins and uses therefore